Trial Profile
A study to evaluate the effects of resveratrol vs rosuvastatin on lipid profile in patients with essential hypertension
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Dec 2015
Price :
$35
*
At a glance
- Drugs Resveratrol (Primary) ; Rosuvastatin (Primary)
- Indications Essential hypertension
- Focus Therapeutic Use
- 21 Dec 2015 New trial record